{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:37:33Z","timestamp":1782513453069,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.trecan.2022.01.005","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T06:00:04Z","timestamp":1643608804000},"page":"273-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Understanding the role of sex hormones in cancer for the transgender community"],"prefix":"10.1016","volume":"8","author":[{"given":"Sarah S.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate Z.","family":"Nambiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"O\u2019Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1132-0275","authenticated-orcid":false,"given":"Alison May","family":"Berner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2022.01.005_bb0005","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc.2016.30","article-title":"Sexual dimorphism in cancer","volume":"16","author":"Clocchiatti","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2022.01.005_bb0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12020-020-02197-5","article-title":"Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review","volume":"68","author":"Patel","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.trecan.2022.01.005_bb0015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41416-021-01392-z","article-title":"Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank","volume":"125","author":"Tin Tin","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2022.01.005_bb0020","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1136\/bmj.l1652","article-title":"Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands","volume":"365","author":"De Blok","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.trecan.2022.01.005_bb0025","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.eururo.2018.07.024","article-title":"Low free testosterone and prostate cancer risk: a collaborative analysis of 20 prospective studies","volume":"74","author":"Watts","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.trecan.2022.01.005_bb0030","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1210\/clinem\/dgaa412","article-title":"Prostate cancer incidence under androgen deprivation: nationwide cohort study in trans women receiving hormone treatment","volume":"105","author":"de Nie","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.trecan.2022.01.005_bb0035","doi-asserted-by":"crossref","first-page":"T219","DOI":"10.1530\/ERC-13-0508","article-title":"Estrogen receptor beta in prostate cancer: friend or foe?","volume":"21","author":"Nelson","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.trecan.2022.01.005_bb0040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1387\/ijdb.130015fg","article-title":"Effect of endogenous and exogenous hormones on testicular cancer: the epidemiological evidence","volume":"57","author":"Giannandrea","year":"2013","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.trecan.2022.01.005_bb0045","article-title":"Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort study","author":"de Nie","year":"2021","journal-title":"BJU Int."},{"key":"10.1016\/j.trecan.2022.01.005_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40738-016-0029-2","article-title":"Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review","volume":"2","author":"Harris","year":"2016","journal-title":"Fertil. Res. Pract."},{"key":"10.1016\/j.trecan.2022.01.005_bb0055","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ecl.2019.02.005","article-title":"Cancer risk in transgender people","volume":"48","author":"de Blok","year":"2019","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.trecan.2022.01.005_bb0060","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/djab028","article-title":"Cancer stage, treatment, and survival among transgender patients in the United States","volume":"113","author":"Jackson","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.trecan.2022.01.005_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2020.100597","article-title":"Inclusion of transgender and gender diverse health data in cancer biorepositories","volume":"19","author":"Jones","year":"2020","journal-title":"Contemp. Clin. Trials Commun."},{"key":"10.1016\/j.trecan.2022.01.005_bb0070","first-page":"102","article-title":"Studying trans: recommendations for ethical recruitment and collaboration with transgender participants in academic research","volume":"9","author":"Vincent","year":"2018","journal-title":"Psychol. Sex."},{"key":"10.1016\/j.trecan.2022.01.005_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1210\/er.2018-00011","article-title":"Endocrinology of transgender medicine","volume":"40","author":"T\u2019Sjoen","year":"2019","journal-title":"Endocr. Rev."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803322000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803322000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:54:45Z","timestamp":1762505685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803322000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2405803322000127"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2022.01.005","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the role of sex hormones in cancer for the transgender community","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2022.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}